Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > St- Michaels Hospital

<< Previous

Bullboard Posts

Next >>

Comment by skys1on Oct 25, 2021 2:26pm

249 Views

Post# 34046233

RE:RE:RE:RE:St- Michaels Hospital

What would it take? Just what I have been saying for the past year or so. When that CR ratio gets up around 60% or so which can happen within the next 6 months or so, I believe something will happen because nothing has ever approached that level before with NMIBC. That would substantially answer any questions left about does this novel approach really work, which I believe is the last stumbling block.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season